Skip to content

Author

Rıfat Bozkuş

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Intensive care unit admissions in adult cystic fibrosis patients: A national cohort study from Türkiye

Objective: Improvements in survival have led to a growing adult population with cystic fibrosis (CF), increasing the relevance of intensive care unit (ICU) management in this group. However, nationwide data on ICU utilization and outcomes in CF remain limited. Materials and Methods: This nationwide retrospective cohort...

Mehmet Yıldırım, Emin Gemcioğlu, Rıfat Bozkuş et al. · 0 citations
Open access Sep 2026

Prognostic significance of the glucose-to-lymphocyte ratio in acute pulmonary embolism.

Background Acute pulmonary embolism has a heterogeneous clinical course, and simple laboratory markers reflecting metabolic and inflammatory stress may provide additional prognostic information. We investigated the association between the glucose-to-lymphocyte ratio (GLR) and in-hospital mortality in acute pulmonary em...

E. Saraçoğlu, Y. E. Özbebek, Derya Doğan et al. · 0 citations
Sep 2026

“Life still has meaning for me!” Exploring sources of meaningful life among palliative care patients: a qualitative study

How individuals receiving inpatient palliative care at a tertiary hospital in Turkey construct and sustain meaning in their daily lives is explored to help preserve continuity, dignity, and emotional well-being.

Hazal Sonbahar Ulu, Güleser Güney Yılmaz, Ayşenur Baysal Yiğit et al. · 0 citations
Open access Aug 2026

Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye.

The role of FIB-4 as a simple, cost-effective tool for integrated cardio-hepato-renal risk stratification is supported, and impaired kidney function in patients with MASLD beyond established cardiometabolic risk factors is independently associated with impaired kidney function in patients with MASLD.

H. Sumbul, A. Kırık, S. Yaylacı et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.